Technical Analysis for GENE - Genetic Technologies Ltd

Grade Last Price % Change Price Change
F 0.77 -1.92% -0.02
GENE closed down 1.92 percent on Wednesday, October 16, 2024, on approximately normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup -1.92%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.92%
Crossed Above 20 DMA Bullish -1.92%
Bollinger Band Squeeze Range Contraction -1.92%
Inside Day Range Contraction -1.92%
Up 3 Days in a Row Strength -1.92%
Up 4 Days in a Row Strength -1.92%
Up 5 Days in a Row Strength -1.92%
20 DMA Resistance Bearish 1.99%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Genetic Technologies Ltd Description

Genetic Technologies Limited provides genetic testing services. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine cancer; neurogenetic diagnostic assays; and gene testing for gene related disorders. The company also provides forensics tests, such as presumptive and confirmatory testing, individual DNA profiling, species identification, and animal forensic testing; paternity tests, which include antenatal, deceased estate, grandparent, immigration, legal paternity, non-legal paternity, sibling, twins, and Y-Chromosome DNA testing, as well as DNA profiling; and personal DNA testing comprising sports performance and ancestry gene testing. In addition, it offers animals' tests consisting of disease testing, breed identification, coat color, and forensic DNA testing, as well as DNA clinical services; and plant tests, including genomic and Xpress sequencing services. Further, the company is involved in the out-licensing of its intellectual property relating to non-coding DNA; and research and development activities in the areas of genetics and related fields. It operates in Australia, the United States, China, Canada, and Switzerland. The company was formerly known as Duketon Goldfields N.L. and changed it name to Genetic Technologies Limited in August 2000 as a result of the change in business from mining to biotechnology. Genetic Technologies Limited is headquartered in Fitzroy, Australia.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Cancer Biology Disease Breast Cancer Genetics Ovarian Cancer Medical Test Applied Genetics Genetic Testing DNA Clinical Services Forensics Immigration DNA Paternity Testing Genetic Testing Services Uterine Cancer

Is GENE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.7745
52 Week Low 0.6666
Average Volume 20,848
200-Day Moving Average 1.75
50-Day Moving Average 0.81
20-Day Moving Average 0.76
10-Day Moving Average 0.75
Average True Range 0.04
RSI (14) 45.65
ADX 41.15
+DI 10.94
-DI 26.52
Chandelier Exit (Long, 3 ATRs) 0.71
Chandelier Exit (Short, 3 ATRs) 0.80
Upper Bollinger Bands 0.81
Lower Bollinger Band 0.71
Percent B (%b) 0.55
BandWidth 13.10
MACD Line -0.02
MACD Signal Line -0.03
MACD Histogram 0.0071
Fundamentals Value
Market Cap 2.94 Million
Num Shares 3.85 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -5.88
Price-to-Sales 0.75
Price-to-Book 1.02
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.80
Resistance 3 (R3) 0.81 0.80 0.80
Resistance 2 (R2) 0.80 0.79 0.80 0.79
Resistance 1 (R1) 0.78 0.78 0.78 0.78 0.79
Pivot Point 0.77 0.77 0.77 0.77 0.77
Support 1 (S1) 0.76 0.76 0.75 0.75 0.74
Support 2 (S2) 0.75 0.76 0.75 0.74
Support 3 (S3) 0.73 0.75 0.73
Support 4 (S4) 0.73